Spyre Therapeutics Inc

Is SYRE’s price to cash per share ratio a concern for investors?

Patricia Turner

Spyre Therapeutics Inc (SYRE)’s stock is trading at $29.23 at the moment marking a rise of 1.98% from the last ...

Understanding SYRE stock ratios for better investment decisions

Preston Campbell

Spyre Therapeutics Inc (SYRE)’s stock has witnessed a price hike of 0.85% from the previous close with its current price ...

A year in review: Spyre Therapeutics Inc (SYRE)’s performance in the last year

Kenneth Phillips

While Spyre Therapeutics Inc has overperformed by 0.58%, investors are advised to look at stock chart patterns for technical insight. ...

Examining SYRE’s book value per share for the latest quarter

Kenneth Phillips

Currently, Spyre Therapeutics Inc’s (SYRE) stock is trading at $22.71, marking a fall of -7.15% from last night’s close. At ...

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.